We are very pleased to announce that, in a short period and thanks to the Endeavor Scale Up and Endeavor Alumni programs, Avedian has successfully closed its pre-series A round. This milestone represents a decisive step towards our commitment to transform healthcare through the use of artificial intelligence and personalized, preventive, predictive, and participatory medicine models.
With a clear vision towards the Plan 2030, we have selected the strategic players who, together with us, will lead Avedian to become a high-impact company in the healthcare sector.
Meet Capital and its team
We especially thank Meet Capital, a fund specialized in Latin American B2B startups, whose members are key to our new stage:
- Gabriel Florensa
Angel investor with a portfolio of more than 10 technology companies and extensive experience in startups. - Carlos Villagra
President of various companies and consultant specialized in financial solutions, mergers and acquisitions, and asset restructuring.
Gabriel Allasia as investor and advisory board member
For the last 18 years, he has worked at Globant in different positions with global reach as Staffing Manager, VP of Operations, and VP Corporate Development leading the M Integration Area for the last 6 years. A fundamental role for Avedian’s next steps.
Additionally, the round was completed by private investors with extensive experience in the sector, who share our vision and commitment to innovation in healthcare.
Meet Capital and its team
With active operations in Mexico, Argentina, Colombia, Peru, Ecuador, and the Dominican Republic, Avedian aims to expand its customer network by 4x in the next year and consolidate its structure for the next round.
We want to express our sincere gratitude to Endeavor for their constant support and for being with us on this journey.
For more information about Avedian, please visit https://avedian.tech/
